Related Experiment Videos
Studies on bovine spleen cathepsin D.
Summary
Purifying the enzyme cathepsin D using affinity chromatography yields a stable, single-chain molecule. This purified cathepsin D exhibits primarily unordered structure, with limited alpha-helix content, and its interaction with pepstatin is pH-dependent.
Area of Science:
- Biochemistry
- Enzymology
- Protein Chemistry
Background:
- Cathepsin D is a key aspartic protease involved in various cellular processes.
- Previous purification methods often resulted in degradation of the enzyme.
- Understanding the structural properties and substrate specificity of cathepsin D is crucial for its functional characterization.
Purpose of the Study:
- To develop an effective purification strategy for obtaining intact cathepsin D.
- To characterize the structural features of purified cathepsin D using biophysical techniques.
- To investigate the substrate specificity and inhibitor binding properties of cathepsin D.
Main Methods:
- Purification of cathepsin D utilizing affinity chromatography.
- Determination of molecular weight and N-terminal amino acid sequencing.
- Circular Dichroism (CD) spectroscopy for structural analysis.
- Enzyme specificity assays using synthetic substrates.
- Pepstatin binding studies at varying pH conditions.
Main Results:
- A robust purification method yielded a single polypeptide chain of 42,000 daltons, with glycine as the N-terminal amino acid.
- CD measurements indicated a predominantly unordered structure, with approximately 26% beta-structure and 5% alpha-helix.
- Pepstatin binding induced significant changes in the CD spectrum between 250-300 nm, with no observed interaction above pH 7.5.
Conclusions:
- Affinity chromatography is an effective method for purifying functional cathepsin D, preserving its single-chain integrity.
- Cathepsin D possesses a largely unstructured conformation with specific secondary structure elements.
- Pepstatin inhibition of cathepsin D is sensitive to pH, suggesting a role for protonation states in inhibitor binding.